Katherine High talks gene therapy progress for hemophilia & inherited retinopathies

(Mary Ann Liebert, Inc./Genetic Engineering News) Gene therapy has shown some of its most promising early results in treating patients with hemophilia and inherited retinal disorders that cause vision loss and blindness, both important research and drug development targets during the career of Katherine High, M.D., President and Chief Scientific Officer of Spark Therapeutics.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news